Streetbeat News

Price Targets

CLVT

Wells Fargo analyst Seth Weber downgraded Clarivate (NYSE:CLVT) from Equal-Weight to Underweight and set a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:35 pm

LHX

Deutsche Bank analyst Scott Deuschle upgraded L3Harris Technologies (NYSE:LHX) from Hold to Buy and increased the price target from $184 to $240.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:31 pm

BKD

B of A Securities analyst Joanna Gajuk upgraded Brookdale Senior Living (NYSE:BKD) from Underperform to Neutral and increased the price target from $3.95 to $6, potentially indicating an improved outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:23 pm

BTC-USD

ETH-USD

Veteran trader Peter Brandt expressed skepticism about Ethereum's future, suggesting it may not be a tradable asset in 10 years due to high gas prices and inferior store of value compared to Bitcoin. Despite recent gains in the crypto market, Brandt advised watching the ETH-BTC ratio, hinting at a potential decline if it doesn't hold above a certain level.

Portfolio Pulse from Mehab Qureshi

December 15, 2023 | 12:20 pm

INTC

B of A Securities analyst Vivek Arya has upgraded Intel (NASDAQ:INTC) from Underperform to Neutral and increased the price target from $32 to $50.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:19 pm

CHD

B of A Securities analyst Anna Lizzul upgraded Church & Dwight Co (NYSE:CHD) from Underperform to Neutral and increased the price target from $85 to $100.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:14 pm

APLS

Oppenheimer analyst Justin Kim has maintained an Outperform rating on Apellis Pharmaceuticals (NASDAQ:APLS) but has reduced the price target from $88 to $75.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:13 pm

CLX

B of A Securities analyst Anna Lizzul upgraded Clorox (NYSE:CLX) from Underperform to Neutral and increased the price target from $120 to $150.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:12 pm

CL

B of A Securities analyst Bryan Spillane has upgraded Colgate-Palmolive (NYSE:CL) from Neutral to Buy and set a price target of $90.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:11 pm

MU

B of A Securities analyst Vivek Arya upgraded Micron Technology (NASDAQ:MU) from Neutral to Buy and increased the price target from $77 to $95, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 15, 2023 | 12:09 pm